Treatment

Interferon Gamma 1-b clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE2, PHASE3
Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo
This study looks at whether a medicine called Interferon Gamma 1-b can help critically ill adults in intensive care bounce back after their immune system has been weakened. This weakening, called post-aggressive immunosuppression (PAIS), can lead to more infections and complications.
For: Post-aggressive Immunosuppression · Adult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6 · Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
France